Walleye Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.97M | Buy |
40,403
+24,566
| +155% | +$4.24M | 0.03% | 334 |
|
|
2025
Q1 | $2.47M | Buy |
+15,837
| New | +$2.47M | 0.01% | 541 |
|
|
2024
Q4 | – | Sell |
-1,014
| Closed | -$151K | – | 2095 |
|
|
2024
Q3 | $151K | Buy |
1,014
+458
| +82% | +$68.4K | ﹤0.01% | 1782 |
|
|
2024
Q2 | $75.8K | Buy |
556
+527
| +1,817% | +$71.9K | ﹤0.01% | 2107 |
|
|
2024
Q1 | $4.38K | Sell |
29
-1,133
| -98% | -$171K | ﹤0.01% | 2447 |
|
|
2023
Q4 | $146K | Buy |
+1,162
| New | +$146K | ﹤0.01% | 1546 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2267 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2089 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 2129 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2132 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2273 |
|